Scoring microvascular invasion in hepatocellular carcinoma:are we meeting the grade?

作     者：Derek J.Erstad Kenneth K.Tanabe 

作者机构：Division of Surgical OncologyBaylor College of MedicineHoustonTXUSA Division of Gastrointestinal and Oncologic SurgeryHarvard Medical School and Massachusetts General HospitalBostonMAUSA 

出 版 物：《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养（英文）)

年 卷 期：2024年第13卷第1期

页      面：184-187页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

主　　题：Microvascular invasion(MVI) hepatocellular carcinoma(HCC) hepatectomy 

摘      要：Hepatocellular carcinoma(HCC)is the second leading cause of cancer-related mortality and has rising global incidence(1).A perplexing aspect of this disease is the high rate of recurrence(50-70%)after curative-intent,margin negative surgical resection(2).While de novo HCC arising from baseline chronic liver injury is a driver of late recurrences,most recurrences occur over a short interval and are thought to be spread from the index malignancy.